Activin A and Betacellulin

Effect on Regeneration of Pancreatic β-Cells in Neonatal Streptozotocin-Treated Rats

Lei Li, Zhaohong Yi, Masaharu Seno, Itaru Kojima

Research output: Contribution to journalArticle

101 Citations (Scopus)

Abstract

Activin A and betacellulin (BTC) are thought to regulate differentiation of pancreatic β-cells during development and regeneration of β-cells in adults. In the present study, we used neonatal rats treated with streptozotocin (STZ) to investigate the effects of activin A and BTC on regeneration of pancreatic β-cells. One-day-old Sprague-Dawley rats were injected with STZ (85 μg/g) and then administered for 7 days with activin A and/or BTC. Treatment with activin A and BTC significantly reduced the plasma glucose concentration and the plasma glucose response to intraperitoneal glucose loading. The pancreatic insulin content and β-cell mass in rats treated with activin A and BTC were significantly increased compared with the control group on day 8 and at 2 months. Treatment with activin A and BTC significantly increased the DNA synthesis in preexisting β-cells, ductal cells, and δ-cells. The number of islet cell-like clusters (ICCs) and islets was significantly increased by treatment with activin A and BTC. In addition, the number of insulin/somatostatin-positive cells and pancreatic duodenal homeobox-1/somatostatin-positive cells was significantly increased. These results indicate that, in neonatal STZ-treated rats, a combination of activin A and BTC promoted regeneration of pancreatic β-cells and improved glucose metabolism in adults.

Original languageEnglish
Pages (from-to)608-615
Number of pages8
JournalDiabetes
Volume53
Issue number3
DOIs
Publication statusPublished - Mar 2004

Fingerprint

Streptozocin
Regeneration
Glucose
Somatostatin-Secreting Cells
Insulin
Betacellulin
activin A
Homeobox Genes
Islets of Langerhans
Sprague Dawley Rats
Cell Differentiation
Control Groups
DNA

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Activin A and Betacellulin : Effect on Regeneration of Pancreatic β-Cells in Neonatal Streptozotocin-Treated Rats. / Li, Lei; Yi, Zhaohong; Seno, Masaharu; Kojima, Itaru.

In: Diabetes, Vol. 53, No. 3, 03.2004, p. 608-615.

Research output: Contribution to journalArticle

@article{fe1146cf1fff489eb1ae69440f768887,
title = "Activin A and Betacellulin: Effect on Regeneration of Pancreatic β-Cells in Neonatal Streptozotocin-Treated Rats",
abstract = "Activin A and betacellulin (BTC) are thought to regulate differentiation of pancreatic β-cells during development and regeneration of β-cells in adults. In the present study, we used neonatal rats treated with streptozotocin (STZ) to investigate the effects of activin A and BTC on regeneration of pancreatic β-cells. One-day-old Sprague-Dawley rats were injected with STZ (85 μg/g) and then administered for 7 days with activin A and/or BTC. Treatment with activin A and BTC significantly reduced the plasma glucose concentration and the plasma glucose response to intraperitoneal glucose loading. The pancreatic insulin content and β-cell mass in rats treated with activin A and BTC were significantly increased compared with the control group on day 8 and at 2 months. Treatment with activin A and BTC significantly increased the DNA synthesis in preexisting β-cells, ductal cells, and δ-cells. The number of islet cell-like clusters (ICCs) and islets was significantly increased by treatment with activin A and BTC. In addition, the number of insulin/somatostatin-positive cells and pancreatic duodenal homeobox-1/somatostatin-positive cells was significantly increased. These results indicate that, in neonatal STZ-treated rats, a combination of activin A and BTC promoted regeneration of pancreatic β-cells and improved glucose metabolism in adults.",
author = "Lei Li and Zhaohong Yi and Masaharu Seno and Itaru Kojima",
year = "2004",
month = "3",
doi = "10.2337/diabetes.53.3.608",
language = "English",
volume = "53",
pages = "608--615",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "3",

}

TY - JOUR

T1 - Activin A and Betacellulin

T2 - Effect on Regeneration of Pancreatic β-Cells in Neonatal Streptozotocin-Treated Rats

AU - Li, Lei

AU - Yi, Zhaohong

AU - Seno, Masaharu

AU - Kojima, Itaru

PY - 2004/3

Y1 - 2004/3

N2 - Activin A and betacellulin (BTC) are thought to regulate differentiation of pancreatic β-cells during development and regeneration of β-cells in adults. In the present study, we used neonatal rats treated with streptozotocin (STZ) to investigate the effects of activin A and BTC on regeneration of pancreatic β-cells. One-day-old Sprague-Dawley rats were injected with STZ (85 μg/g) and then administered for 7 days with activin A and/or BTC. Treatment with activin A and BTC significantly reduced the plasma glucose concentration and the plasma glucose response to intraperitoneal glucose loading. The pancreatic insulin content and β-cell mass in rats treated with activin A and BTC were significantly increased compared with the control group on day 8 and at 2 months. Treatment with activin A and BTC significantly increased the DNA synthesis in preexisting β-cells, ductal cells, and δ-cells. The number of islet cell-like clusters (ICCs) and islets was significantly increased by treatment with activin A and BTC. In addition, the number of insulin/somatostatin-positive cells and pancreatic duodenal homeobox-1/somatostatin-positive cells was significantly increased. These results indicate that, in neonatal STZ-treated rats, a combination of activin A and BTC promoted regeneration of pancreatic β-cells and improved glucose metabolism in adults.

AB - Activin A and betacellulin (BTC) are thought to regulate differentiation of pancreatic β-cells during development and regeneration of β-cells in adults. In the present study, we used neonatal rats treated with streptozotocin (STZ) to investigate the effects of activin A and BTC on regeneration of pancreatic β-cells. One-day-old Sprague-Dawley rats were injected with STZ (85 μg/g) and then administered for 7 days with activin A and/or BTC. Treatment with activin A and BTC significantly reduced the plasma glucose concentration and the plasma glucose response to intraperitoneal glucose loading. The pancreatic insulin content and β-cell mass in rats treated with activin A and BTC were significantly increased compared with the control group on day 8 and at 2 months. Treatment with activin A and BTC significantly increased the DNA synthesis in preexisting β-cells, ductal cells, and δ-cells. The number of islet cell-like clusters (ICCs) and islets was significantly increased by treatment with activin A and BTC. In addition, the number of insulin/somatostatin-positive cells and pancreatic duodenal homeobox-1/somatostatin-positive cells was significantly increased. These results indicate that, in neonatal STZ-treated rats, a combination of activin A and BTC promoted regeneration of pancreatic β-cells and improved glucose metabolism in adults.

UR - http://www.scopus.com/inward/record.url?scp=1442276960&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1442276960&partnerID=8YFLogxK

U2 - 10.2337/diabetes.53.3.608

DO - 10.2337/diabetes.53.3.608

M3 - Article

VL - 53

SP - 608

EP - 615

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 3

ER -